Cargando…

Neural grafting for Parkinson's disease: challenges and prospects

Parkinson's disease (PD) is a neurodegenerative condition which causes a characteristic movement disorder secondary to loss of dopaminergic neurons in the substanitia nigra. The motor disorder responds well to dopamine-replacement therapies, though these result in significant adverse effects du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoker, Thomas B., Blair, Nicholas F., Barker, Roger A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399709/ https://www.ncbi.nlm.nih.gov/pubmed/28469646 http://dx.doi.org/10.4103/1673-5374.202935

Ejemplares similares

Recent developments in the treatment of Parkinson's Disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Cell therapies for Parkinson's disease: how far have we come?
por: Stoker, Thomas B, et al.
Publicado: (2016)

Emerging Treatment Approaches for Parkinson’s Disease
por: Stoker, Thomas B., et al.
Publicado: (2018)

Tracking of iron-labeled human neural stem cells by magnetic resonance imaging in cell replacement therapy for Parkinson's disease
por: Ramos-Gómez, Milagros, et al.
Publicado: (2016)

Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021)

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

The Epigenome as a therapeutic target for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2016)

Neuroinflammation in Parkinson’s Disease and its Treatment Opportunities
por: Çınar, Elif, et al.
Publicado: (2022)

Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects
por: Mouhieddine, Tarek H., et al.
Publicado: (2014)

MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease
por: Kinghorn, Kerri J., et al.
Publicado: (2017)

Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy
por: Sampaio, Tuane Bazanella, et al.
Publicado: (2017)

The treatment of Parkinson's disease with deep brain stimulation: current issues
por: Moldovan, Alexia-Sabine, et al.
Publicado: (2015)

Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
por: Béraud, Dawn, et al.
Publicado: (2012)

New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases
por: Hölscher, Christian
Publicado: (2014)

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2014)

Extracellular matrices, artificial neural scaffolds and the promise of neural regeneration
por: Ricks, Christian B., et al.
Publicado: (2014)

Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases
por: Freyssin, Aline, et al.
Publicado: (2018)

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
por: Lauterbach, Edward C.
Publicado: (2016)

TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's disease
por: Binukumar, BK, et al.
Publicado: (2016)

Positron Emission Tomography in the Differential Diagnosis of Parkinsonism
por: Rinne, Juha O
Publicado: (2009)

An update–tissue engineered nerve grafts for the repair of peripheral nerve injuries
por: Patel, Nitesh P., et al.
Publicado: (2018)

Nanobiomaterials for neural regeneration
por: Chen, Nuan, et al.
Publicado: (2016)

The Current Status of Neural Grafting in the Treatment of Huntington’s Disease. A Review
por: Wijeyekoon, Ruwani, et al.
Publicado: (2011)

Brain injury and neural stem cells
por: Ludwig, Parker E., et al.
Publicado: (2018)

The p75 neurotrophin receptor: at the crossroad of neural repair and death
por: Meeker, Rick B., et al.
Publicado: (2015)

Harnessing migraines for neural regeneration
por: Borkum, Jonathan M.
Publicado: (2018)

Application of single-cell genomics in cancer: promise and challenges
por: Wills, Quin F., et al.
Publicado: (2015)

LRRK2 and membrane trafficking: nexus of Parkinson’s disease
por: Hur, Eun-Mi, et al.
Publicado: (2019)

RACK1 regulates neural development
por: Kershner, Leah, et al.
Publicado: (2017)

Hitting the right target: taxonomic challenges for, and of, plant invasions
por: Pyšek, Petr, et al.
Publicado: (2013)

Challenges and Opportunities of Airborne Metagenomics
por: Behzad, Hayedeh, et al.
Publicado: (2015)

Optogenetics and its application in neural degeneration and regeneration
por: Ordaz, Josue D., et al.
Publicado: (2017)

Perspectives on the neural connectivity of the fornix in the human brain
por: Jang, Sung Ho, et al.
Publicado: (2014)

PTEN inhibition and axon regeneration and neural repair
por: Ohtake, Yosuke, et al.
Publicado: (2015)

Limitations of Continuous Neural Monitoring in Thyroid Surgery
por: Caruso, Ettore, et al.
Publicado: (2019)

The knowns and unknowns of neural adaptations to resistance training
por: Škarabot, Jakob, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_12oen6v88nvipd0h2dh0tm56ur